Allorion Therapeutics

Series-B+
alloriontx.com Biotech & Healthcare Natick, United States 11-50
Total Funding $50M
Latest Round $50M Series-B+
Last Announced Mar 10, 2023
Investors 10 Backers
Decision Makers 4 Verified

About Allorion Therapeutics

Developing novel small molecule drugs against cancer and autoimmune diseases.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Natick, United States
Team Size 11-50
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website alloriontx.com
Domain Registered Date Oct 28, 2019

Social & Network Presence

X / Twitter Profile @AllorionT (21 followers) Created on Feb 2021
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $50,000,000 · Series-B+

    fundraisingfox.com

  2. Capital Raise

    Series-A announced

  3. Milestone

    X account created (@AllorionT)

    21 followers

  4. Milestone

    Website domain registered

    alloriontx.com

Investors & Backers

10
3SBio Inc.
Elikon Venture
FirstLight Capital
IDG Capital
INCE Capital
LongRiver Investments
Med-Fine Capital
Octagon Capital Advisors
Qiming Venture Partners
TF Capital

Funding History

2 Rounds
Series-B+ · Mar 10, 2023
Series-A · Nov 24, 2021
Undisclosed Source

Founders & Leadership

1

Qiang Ding

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts